Patents for C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069) |
---|
06/17/2010 | DE102008061843A1 Heterocyclische Verbindungen und deren Verwendung in elektronischen und optoelektronischen Bauelementen Heterocyclic compounds and their use in electronic and optoelectronic devices |
06/17/2010 | CA2744456A1 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives |
06/15/2010 | US7737269 Process for preparing an alpha-lipoic acid/cyclodextrin complex and product prepared |
06/15/2010 | US7737145 Diamine derivatives as inhibitors of leukotriene A4 hydrolase |
06/10/2010 | US20100144735 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy |
06/09/2010 | CN1852712B Dual NK1/NK3 antagonists for treating schizophrenia |
06/08/2010 | US7732604 Triazolopyrazine derivatives |
06/08/2010 | US7732603 Organic compounds as agents for the treatment of aldosterone mediated conditions |
06/08/2010 | US7732507 Spirotetrathiocarbamates and spirooxothiocarbamates |
06/08/2010 | US7732454 Inhibitors of Bruton's tyrosine kinase |
06/08/2010 | US7732435 vanilloid receptor antagonists such as 7-(4-Chlorophenyl)-6-isopropyl-3-methyl-2,3-dihydro-1H-1-aza-4,5-dioxa-phenanthren-8-one, used for treating nociceptive pain; analgesics |
05/25/2010 | US7723349 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions |
05/25/2010 | CA2369232C Fused pyrazolyl compounds |
05/14/2010 | WO2010017093A3 Dopamine receptor ligands with enhanced duration of action |
05/11/2010 | US7714018 Heterocyclic antiviral compounds |
04/29/2010 | WO2010046388A1 Substituted (aza) -1-methyl-1h-quinolin-2-ones as antibacterials |
04/29/2010 | WO2010045987A1 Substituted (aza) -1-methyl-1h-quin0lin-2-0nes as antibacterials |
04/22/2010 | WO2010043714A1 Tricyclic nitrogen compounds used as antibacterials |
04/22/2010 | US20100098630 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides |
04/21/2010 | EP1963324B1 Heterocyclic compounds, their preparation and their use as antibacterials |
04/01/2010 | WO2010037068A2 Dithienofuran dyes for imaging and therapy |
04/01/2010 | CA2737915A1 Dithienofuran dyes for imaging and therapy |
03/30/2010 | US7687627 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy |
03/30/2010 | US7687086 Method for obtaining taxanes |
03/17/2010 | CN101675059A Macrocyclic compound |
03/11/2010 | WO2010026974A1 Process for production of sultone derivative |
03/02/2010 | US7671088 Water-soluble etoposide analogs and methods of use thereof |
02/24/2010 | EP2155659A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
02/11/2010 | WO2010017093A2 Dopamine receptor ligands with enhanced duration of action |
01/07/2010 | WO2010001913A1 Acrylate derivative, haloester derivative, polymer compound and photoresist composition |
12/29/2009 | US7638546 Imidazolyl derivatives |
12/24/2009 | US20090318592 Process for the Synthesis of Amine Ethers |
12/24/2009 | US20090318548 Para-quinol derivatives and methods of stereo selectively synthesizing and using same |
12/01/2009 | US7625899 antiproliferative, antitumor and anticarcinogenic agent; cyclin dependent kinase inhibitor |
11/19/2009 | WO2009138440A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs |
11/19/2009 | US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators |
11/19/2009 | CA2724215A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs |
11/18/2009 | EP2119718A1 Macrocyclic compound |
11/18/2009 | EP0764168B1 Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom |
10/29/2009 | WO2009129938A1 Substituted phenoxybenzamides |
10/27/2009 | US7608622 1 -Phenylerhyl)-6-(3,4,5-trimethoxyphenyl)- 1 ,3-dihydroimidazo[4,5-b]pyrazin-2-one; |
10/14/2009 | CN100548988C Metabolites of ecteinascidin 743 |
10/01/2009 | WO2009117829A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby |
10/01/2009 | CA2756800A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby |
08/26/2009 | CN101516889A Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
08/19/2009 | CN100528882C Spirotetrathiocarbamates and spirooxothiocarbamates |
08/18/2009 | US7576085 Imidazo[1,2-a]pyrazine compounds; cancers |
08/18/2009 | US7575890 Method for rapid detection and evaluation of cultured cell growth |
08/13/2009 | US20090203676 G-protein Coupled Receptor Agonists |
08/05/2009 | EP1805144A4 Heterocyclical chromophore architectures |
07/28/2009 | US7566734 Imidazolyl derivatives |
07/22/2009 | EP1567524B1 Thia-epothilone derivatives for the treatment of cancer |
07/22/2009 | CN100516066C Compounds for treating impaired fundic relaxation |
07/16/2009 | WO2009087153A1 Tricyclic nitrogen compounds and their use as antibacterial agents |
07/16/2009 | US20090182146 Process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3')quiniclidine hydrochloride |
07/15/2009 | EP1863774A4 Heterocyclical chromophore architectures with novel electronic acceptor systems |
07/15/2009 | EP1805150A4 Heterocyclical chromophore architectures |
07/08/2009 | EP1073647B1 12,13-cyclopropane epothilone derivatives |
06/30/2009 | US7553859 Macrocycles for the treatment of cancer |
06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
06/10/2009 | EP2066676A1 HETEROCYCLIC INHIBITORS OF c-MET AND USES THEREOF |
06/09/2009 | US7544682 cancer; Methyl 5-((7-(((tert-butylamino)carbonyl)amino)-6-(2,6-dichlorophenyl)pyrido[2,3-d] pyrimidin-2-yl)amino)-1,3-benzodioxole-2-carboxylate; treating cellular proliferation disorders |
06/02/2009 | CA2474205C E2 displacement assay for identifying inhibitors of hpv |
05/28/2009 | US20090137806 Dual nk1/nk3 receptor antagonists |
05/19/2009 | US7534797 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors |
05/14/2009 | US20090124649 Aza spiro alkane derivatives as inhibitors of metalloproteases |
04/23/2009 | WO2009051752A1 Novel lapachone compounds and methods of use thereof |
04/23/2009 | US20090105166 Novel lapachone compounds and methods of use thereof |
04/22/2009 | EP2049516A2 Pharmaceutical compounds |
04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
04/14/2009 | US7517532 Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
04/08/2009 | EP2044077A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
04/08/2009 | CN101405282A Aurora kinase modulators and method of use |
03/31/2009 | US7511041 Fused azole-pyrimidine derivatives |
03/18/2009 | EP2035435A1 Novel lapachone compounds and methods of use thereof |
03/18/2009 | CN101389632A Spiroketals |
03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
02/26/2009 | WO2009026345A1 Thiazolidinone compounds, and methods of making and using same |
02/25/2009 | EP1521752B1 Macrocycles for the treatment of cancer |
02/12/2009 | US20090043097 Methods |
01/07/2009 | EP2010532A1 Tryclic nitrogen containing compounds and their use as antibacterials |
01/01/2009 | US20090004508 Thin-film materials, thin films and producing method thereof |
12/31/2008 | WO2008011406A3 Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
12/04/2008 | WO2008144982A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome |
12/04/2008 | CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome |
12/02/2008 | US7459554 Anticancer agent; 1-(3-Benzyloxy-phenyl)-3-cyclobutyl-imidazo[1,5-a]pyrazin-8-ylamine |
11/20/2008 | WO2008138639A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
11/20/2008 | CA2686484A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
11/19/2008 | EP1992628A1 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
11/12/2008 | CN101302223A Porphyrin-like-azulene compound, preparation and use thereof |
10/29/2008 | EP1984353A1 Aurora kinase modulators and method of use |
10/21/2008 | US7438833 Organic species that facilitate charge transfer to or from nanostructures |
10/09/2008 | WO2007018660A3 Gabaergic imidazobenzodiazepine derivatives to treat memory deficits |
10/04/2008 | CA2584349A1 Process for the preparation of 2-methylspiro(1,3-oxathiolane-5,3') quiniclidine |
09/24/2008 | EP1971608A1 Spiroketals |
09/09/2008 | US7423048 eating disorders of disturbed fundus such as dyspepsia, early satiety, bloating, anorexia; fundic relaxation; 1-(1-((2,3-dihydro(1,4)dioxino(2,3-b)pyridin-3-yl)methyl) -4- piperidinyl)-2-imidazolidinone; improved pharmacokinetics, less vasoconstriction, side effect reduction, sustain release |
09/04/2008 | WO2008105526A1 Macrocyclic compound |
09/04/2008 | CA2679126A1 Macrocyclic compound |
09/03/2008 | EP1963324A1 Heterocyclic compounds, their preparation and their use as antibacterials |